LEADER 01365nam 2200361 n 450 001 996384370803316 005 20200824121250.0 035 $a(CKB)4940000000066107 035 $a(EEBO)2240914424 035 $a(UnM)ocm99891336e 035 $a(UnM)99891336 035 $a(EXLCZ)994940000000066107 100 $a19901130d1635 uy 101 0 $aeng 135 $aurbn||||a|bb| 200 11$aA quip for an vpstart courtier: or, A quaint dispute betweene velvet-breeches and cloth-breeches$b[electronic resource] $eWherein is plainely set downe the disorders in all estates and trades. /$fBy Robert Greene 210 $aLondon, $cprinted by E. Purslow, dwelling at the east end of Christs-Church$d1635 215 $a[1+] p. $cill 300 $aWith a title-page woodcut. 300 $aA fragment; title page only. 300 $aReproduction of original in the British Library. 330 $aeebo-0018 607 $aEngland$xSocial life and customs$vEarly works to 1800 608 $aTitle pages$zEngland$y17th cent. 700 $aGreene$b Robert$f1558?-1592.$061817 801 0$bCu-RivES 801 1$bCu-RivES 801 2$bCStRLIN 801 2$bCu-RivES 906 $aBOOK 912 $a996384370803316 996 $aA quip for an vpstart courtier: or, A quaint dispute betweene velvet-breeches and cloth-breeches$92316734 997 $aUNISA LEADER 01731oam 2200433 450 001 9910704708903321 005 20131205115611.0 035 $a(CKB)5470000002444640 035 $a(OCoLC)856545318 035 $a(EXLCZ)995470000002444640 100 $a20130821d2013 ua 0 101 0 $aeng 135 $aurbn||||a|||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aFDA user fees 2012 $eissues related to accelerated approval, medical gas, antibiotic development, and downstream pharmaceutical supply chain : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, second session, March 8, 2012 210 1$aWashington :$cU.S. Government Printing Office,$d2013. 215 $a1 online resource (iv, 214 pages) $cillustrations 300 $aTitle from title screen (viewed on Aug. 21, 2013). 300 $aPaper version available for sale by the Superintendent of Documents, U.S. Government Printing Office. 300 $a"Serial no. 112-126." 320 $aIncludes bibliographical references. 517 $aFDA user fees 2012 606 $aDrug approval$zUnited States 606 $aGases$xTherapeutic use$xGovernment policy$zUnited States 606 $aAntibiotics$xDevelopment$zUnited States 606 $aDrugs$zUnited States$xMarketing 615 0$aDrug approval 615 0$aGases$xTherapeutic use$xGovernment policy 615 0$aAntibiotics$xDevelopment 615 0$aDrugs$xMarketing. 801 0$bGPO 801 1$bGPO 801 2$bGPO 906 $aBOOK 912 $a9910704708903321 996 $aFDA user fees 2012$93463567 997 $aUNINA LEADER 00555nus2 2200205 i 450 001 CFI0170842 005 20251003044129.0 100 $a20120118a19..9999||||0itac50 ba 102 $ait 110 $ab|u|||||||| 200 1 $aScienze umane. Politica 210 $a[Milano]$cETAS libri$d[19..]-. 225 | $aScienze umane 410 0$1001CFI0170845$12001 $aScienze umane 801 3$aIT$bIT-000000$c20120118 850 $aIT-NA0070 912 $aCFI0170842 977 $a 01$a BU$a PB 996 $aScienze umane. Politica$91693787 997 $aUNISANNIO